StonvexLoading…
StonvexStonvexStonvexCore line items from SQM's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 | Annual 2021 2021-12-31 |
|---|---|---|---|---|
Revenue | $4.53B | $7.47B | $10.71B | $2.86B |
Operating Income | $1.07B | $2.84B | $5.53B | $927.29M |
Net Income | $691.84M | $930.27M | $3.91B | $592.21M |
EPS (Diluted) | $2.40 | $3.23 | $13.68 | $2.10 |
Total Assets | $11.50B | $10.78B | $10.82B | $7.18B |
Total Liabilities | $6.30B | $6.30B | $5.89B | $3.96B |
Cash & Equivalents | $1.38B | $1.04B | $2.66B | $1.52B |
Free Cash Flow OCF − CapEx | $302.89M | $-1.30B | $3.17B | $357.80M |
Shares Outstanding | Not available | Not available | Not available | Not available |